MeHow Innovative Ltd.

XSEC:301363 Stock Report

Market Cap: CN¥12.3b

MeHow Innovative Valuation

Is 301363 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301363 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301363 (CN¥30.29) is trading below our estimate of fair value (CN¥40.26)

Significantly Below Fair Value: 301363 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301363?

Key metric: As 301363 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 301363. This is calculated by dividing 301363's market cap by their current earnings.
What is 301363's PE Ratio?
PE Ratio45.2x
EarningsCN¥271.08m
Market CapCN¥12.26b

Price to Earnings Ratio vs Peers

How does 301363's PE Ratio compare to its peers?

The above table shows the PE ratio for 301363 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.1x
600055 Beijing Wandong Medical TechnologyLtd
65.7xn/aCN¥12.1b
600587 Shinva Medical InstrumentLtd
15.4x22.3%CN¥10.7b
688139 Qingdao Haier BiomedicalLtd
29.2x30.1%CN¥10.5b
688575 Shenzhen YHLO Biotech
34.1x38.9%CN¥9.8b
301363 MeHow Innovative
45.2x31.5%CN¥12.3b

Price-To-Earnings vs Peers: 301363 is expensive based on its Price-To-Earnings Ratio (45.2x) compared to the peer average (36.1x).

Price to Earnings Ratio vs Industry

How does 301363's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
301363 45.2xIndustry Avg. 34.5xNo. of Companies18PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 301363 is expensive based on its Price-To-Earnings Ratio (45.2x) compared to the CN Medical Equipment industry average (34.5x).

Price to Earnings Ratio vs Fair Ratio

What is 301363's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301363 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio45.2x
Fair PE Ratio34.5x

Price-To-Earnings vs Fair Ratio: 301363 is expensive based on its Price-To-Earnings Ratio (45.2x) compared to the estimated Fair Price-To-Earnings Ratio (34.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 301363 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥30.29
CN¥34.84
+15.0%
13.9%CN¥39.68CN¥30.00n/a2
Nov ’25CN¥31.11
CN¥34.84
+12.0%
13.9%CN¥39.68CN¥30.00n/a2
Oct ’25CN¥34.41
CN¥30.87
-10.3%
2.8%CN¥31.73CN¥30.00n/a2
Sep ’25CN¥29.00
CN¥30.87
+6.4%
2.8%CN¥31.73CN¥30.00n/a2
Aug ’25CN¥26.58
CN¥29.43
+10.7%
2.0%CN¥30.00CN¥28.85n/a2
Jul ’25CN¥29.10
CN¥29.43
+1.1%
2.0%CN¥30.00CN¥28.85n/a2
Jun ’25CN¥25.40
CN¥29.43
+15.8%
2.0%CN¥30.00CN¥28.85n/a2
May ’25CN¥25.71
CN¥29.43
+14.4%
2.0%CN¥30.00CN¥28.85n/a2
Apr ’25CN¥25.95
CN¥41.03
+58.1%
9.7%CN¥45.00CN¥37.05n/a2
Mar ’25CN¥30.15
CN¥41.03
+36.1%
9.7%CN¥45.00CN¥37.05n/a2
Feb ’25CN¥28.20
CN¥41.03
+45.5%
9.7%CN¥45.00CN¥37.05n/a2
Jan ’25CN¥36.80
CN¥41.03
+11.5%
9.7%CN¥45.00CN¥37.05n/a2
Nov ’24CN¥36.50
CN¥44.53
+22.0%
16.8%CN¥52.00CN¥37.05CN¥31.112
Oct ’24CN¥35.36
CN¥46.88
+32.6%
10.9%CN¥52.00CN¥41.75CN¥34.412
Sep ’24CN¥32.99
CN¥46.88
+42.1%
10.9%CN¥52.00CN¥41.75CN¥29.002
Aug ’24CN¥41.73
CN¥51.09
+22.4%
1.8%CN¥52.00CN¥50.18CN¥26.582
Jul ’24CN¥43.99
CN¥50.78
+15.4%
1.7%CN¥52.00CN¥50.15CN¥29.103
Jun ’24CN¥42.93
CN¥51.09
+19.0%
1.8%CN¥52.00CN¥50.18CN¥25.402
May ’24CN¥45.30
CN¥51.09
+12.8%
1.8%CN¥52.00CN¥50.18CN¥25.712
Apr ’24CN¥39.91
CN¥51.21
+28.3%
2.0%CN¥52.23CN¥50.18CN¥25.952

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.7b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.77

7D

-3.4%

1Y

-34.8%

Winner Medical

CN¥19.7b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥33.90

7D

5.4%

1Y

-14.7%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.72

7D

2.3%

1Y

36.8%